Barclays PLC Trans Medics Group, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Barclays PLC holds 190,800 shares of TMDX stock, worth $11.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

190,800

Previous 190,800 -0.0%

Holding current value

$11.8 Million

Previous $30 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$135.68 - $176.11 $11.5 Million - $14.9 Million	84,858 Added 80.1%	190,800 $30 Million
Q2 2024 Aug 14, 2024	SELL	$72.62 - $150.62 $6.66 Million - $13.8 Million	-91,649 Reduced 46.38%	105,942 $16 Million
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $601,601 - $763,505	-8,490 Reduced 4.12%	197,591 $14.6 Million
Q4 2023 Feb 15, 2024	BUY	$36.74 - $81.08 $862,361 - $1.9 Million	23,472 Added 12.85%	206,081 $16.3 Million
Q3 2023 Nov 07, 2023	BUY	$53.47 - $96.07 $1.66 Million - $2.99 Million	31,092 Added 20.52%	182,609 $10 Million
Q2 2023 Aug 03, 2023	BUY	$66.23 - $88.73 $9.01 Million - $12.1 Million	135,977 Added 875.01%	151,517 $12.7 Million
Q1 2023 May 04, 2023	BUY	$53.63 - $82.33 $393,965 - $604,796	7,346 Added 89.65%	15,540 $1.18 Million
Q4 2022 Feb 13, 2023	BUY	$39.08 - $64.29 $269,652 - $443,601	6,900 Added 533.23%	8,194 $506,000
Q3 2022 Nov 03, 2022	SELL	$31.56 - $55.75 $1,767 - $3,122	-56 Reduced 4.15%	1,294 $54,000
Q2 2022 Aug 12, 2022	SELL	$20.56 - $32.15 $61,104 - $95,549	-2,972 Reduced 68.76%	1,350 $42,000
Q1 2022 May 16, 2022	SELL	$12.58 - $26.94 $341,383 - $731,070	-27,137 Reduced 86.26%	4,322 $116,000
Q4 2021 Feb 14, 2022	BUY	$19.16 - $32.68 $399,792 - $681,900	20,866 Added 196.98%	31,459 $603,000
Q3 2021 Nov 09, 2021	BUY	$25.92 - $34.51 $188,179 - $250,542	7,260 Added 217.82%	10,593 $350,000
Q2 2021 Aug 13, 2021	SELL	$21.63 - $40.07 $382,548 - $708,678	-17,686 Reduced 84.14%	3,333 $110,000
Q1 2021 May 13, 2021	BUY	$17.75 - $47.82 $203,805 - $549,069	11,482 Added 120.39%	21,019 $872,000
Q4 2020 Feb 11, 2021	SELL	$11.91 - $19.9 $23,379 - $39,063	-1,963 Reduced 17.07%	9,537 $189,000
Q3 2020 Nov 12, 2020	SELL	$13.78 - $18.84 $11,933 - $16,315	-866 Reduced 7.0%	11,500 $158,000
Q2 2020 Aug 12, 2020	BUY	$11.66 - $18.26 $89,012 - $139,396	7,634 Added 161.33%	12,366 $223,000
Q1 2020 May 13, 2020	SELL	$10.5 - $20.2 $99,865 - $192,122	-9,511 Reduced 66.78%	4,732 $57,000
Q4 2019 Feb 10, 2020	BUY	$16.61 - $21.64 $182,377 - $237,607	10,980 Added 336.5%	14,243 $271,000
Q3 2019 Nov 14, 2019	SELL	$20.27 - $28.93 $138,342 - $197,447	-6,825 Reduced 67.65%	3,263 $77,000
Q2 2019 Aug 14, 2019	BUY	$22.36 - $30.41 $225,567 - $306,776	10,088 New	10,088 $292,000

Others Institutions Holding TMDX

# of Institutions

397

Shares Held

31.7M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $1.96B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account